Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01457196 · ClinicalTrials.gov registry record · NA
Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions
A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 2,798
- Enrollment target
NCT01457196: Completed NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT01457196 is a NA study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 2,798 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01457196, a NA study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,798 participants
- Enrollment target
Study Summary
The primary objective of this specimen correlative study is two-fold: to provide a mechanism for the association of known molecular alterations with clinical outcomes, and to provide rapid genetic profiling of alterations with known clinical utility using tumor and germline specimens to support treatment decisions.
Primary Outcome
To estimate the proportion of patients enrolled on the study who have undergone successful sequencing and have a reportable genetic variant identified
Interventions
- DIAGNOSTIC_TEST Tumor Genetic Sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,798 participants |
| Start Date | 2011-09 |
| Est. Completion | 2018-06-06 |
| Phase | NA |
What the finished NCT01457196 record still lists
NCT01457196 is an interventional study that assigns participants to a tested intervention. Its 2,798 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% higher).
The record links to 0 conditions, and to 1 intervention - of which Tumor Genetic Sequencing is the first listed.
NCT01457196 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01457196 about?
NCT01457196 is a clinical study titled "Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions". The primary objective of this specimen correlative study is two-fold: to provide a mechanism for the association of known molecular alterations with clinical outcomes, and to provide rapid genetic profiling of alterations with known clinical utility using tumor and germline specimens to support trea...
What is the current status of trial NCT01457196?
This trial is currently completed. It is a NA study. The enrollment target is 2,798 participants. The study started on 2011-09. Estimated completion is 2018-06-06.
What interventions are being tested in trial NCT01457196?
The interventions under investigation include: Tumor Genetic Sequencing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01457196?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01457196's enrollment target sits among peer trials
2,798 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443737 · 2,800 participants · Phase 3
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
- NCT05899439 · 2,800 participants
Immune Function and the Progression to T1D
- NCT06089109 · 2,800 participants · NA
Creating VIP Corps to Reduce Maternal Deaths
- NCT06345339 · 2,800 participants · Phase 2
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia